Treating Narcolepsy Around the Clock
New data suggest that targeting the underlying orexin deficiency can improve a broad spectrum of narcolepsy type 1 symptoms, from daytime cognition to nighttime sleep architecture.
Read More
Author: Sree Roy
Why Microsleeps May Redefine ‘Quality of Wake’ in Narcolepsy Type 1
Phase 3 data on the orexin agonist oveporexton suggests that reducing microsleep frequency offers a more accurate reflection of real-world treatment response than traditional wakefulness tests alone.
Read More
Narcolepsy Treatments Are Advancing. Can Access?
Race, age, and other factors are linked to disparities in care for people with narcolepsy.
Read More
The CPAP Mask Feature with Greatest Positive Impact
A recent survey reveals what sleep techs, RTs, and lab managers value most in positive airway pressure interfaces.
Read More
The Push Precision OSA Care Needed
For years, individualized obstructive sleep apnea care has been more aspiration than routine practice. Pharmacologic therapies may help change that.
Read More